Novo Nordisk NVO recently underwent a major leadership transition, as Lars Fruergaard Jørgensen stepped down as CEO on Aug. 7 ...

Bagsværd, Denmark, 16 May 2025– Novo Nordisk today announced changes to its executive leadership and Board of Directors. As per mutual agreement with the Novo Nordisk Board, Lars Fruergaard ...

Novo Nordisk has a commercial relationship with Economist Impact, a division of The Economist Group. The Economist operates ...

On the one hand, the company is struggling to stay competitive with its chief rival Eli Lilly, and on the other, compounders ...

Novo Nordisk CEO Lars Fruergaard Jørgensen Steps Down, Stock Drops In Pre-market May 16, 2025 — 07:57 am EDT Written by RTTNews.com for RTTNews -> ...

Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk, speaks during a TV interview in New York, on Aug. 10, 2022. Getty Images© Christopher Goodney/Bloomberg via Getty Images ...

Novo Nordisk’s outgoing CEO, Lars Fruergaard Jorgensen, has warned that layoffs at the Danish pharmaceutical giant could be ...

Lars Fruergaard Jorgensen's departure comes a week after the company downgraded its sales and profits forecast, and follows a more than 50% decline in the company's shares since mid-2024.

In January 2017, Lars Fruergaard Jorgensen became CEO decades after joining the company as a graduate. In December 2017, Ozempic, also known as semaglutide, gets approved in the U.S. for diabetes ...

Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug ...

CEO Lars Fruergaard Jørgensen said that efforts to bolster supply of the wildly popular weight-loss drug had resulted in the drug's removal from a drug shortage list. "Given the significant ...

Novo Nordisk CEO Lars Fruergaard Jorgensen believes too many American patients are forced to pay large bills for their diabetes treatments, reports Bloomberg. The current drug pricing system ...